John Petrie
@johnrpetrie.bsky.social
Diabetes researcher, diabetes doctor, Clinical Trials Unit Director
Reposted by John Petrie
Hi! We will discuss your article tonight 9 pm EST (I know, difficult hour for your timezone) #NephJC
Here is our take on your article www.nephjc.com/news/metform...
Here is our take on your article www.nephjc.com/news/metform...
Metformin- Should I Stay or Should I Go — NephJC
This week, we will discuss another target trial emulation study. The FDA says to stop metformin at a GFR of 30. Are they right?
www.nephjc.com
April 15, 2025 at 9:12 AM
Hi! We will discuss your article tonight 9 pm EST (I know, difficult hour for your timezone) #NephJC
Here is our take on your article www.nephjc.com/news/metform...
Here is our take on your article www.nephjc.com/news/metform...
SGLT2is were more cardioprotective in older people (despite smaller reductions in HbA1c) and GLP-1 RAs were more cardioprotective in younger people @uofglasgow.bsky.social
February 4, 2025 at 7:58 PM
SGLT2is were more cardioprotective in older people (despite smaller reductions in HbA1c) and GLP-1 RAs were more cardioprotective in younger people @uofglasgow.bsky.social
From David McAllister of University of Glasgow School of Health and Wellbeing using individual patient data meta-analysis and meta-regression . . .
February 4, 2025 at 7:58 PM
From David McAllister of University of Glasgow School of Health and Wellbeing using individual patient data meta-analysis and meta-regression . . .
www.ncbi.nlm.nih.gov/pubmed/39488... Lancet review
Steatotic liver disease - PubMed
Steatotic liver disease is the overarching term for conditions characterised by abnormal lipid accumulation in the liver (liver or hepatic steatosis). Steatotic liver disease encompasses what was prev...
www.ncbi.nlm.nih.gov
December 4, 2024 at 5:27 PM
www.ncbi.nlm.nih.gov/pubmed/39488... Lancet review
DEFINE_ME
www.ajkd.org
November 26, 2024 at 5:05 PM
